Trials / Terminated
TerminatedNCT00764582
Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery
A Randomized, Observer-masked, Parallel-group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmic Solution in Subjects Undergoing Corneal Transplant Surgery
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Santen Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1.5% levofloxacin ophthalmic solution | Topical application Instill 1 drop two times, 5 minutes apart. Time from last drop to surgery is determined by group. Group 1: 30 minutes prior to surgery Group 2: 1 hour prior to surgery Group 3: 2 hours prior to surgery Group 4: 4 hours prior to surgery |
| DRUG | 0.5% moxifloxacin ophthalmic solution | Topical application Instill 1 drop two times, 5 minutes apart. Time from last drop to surgery is determined by group. Group 5: 30 minutes prior to surgery Group 6: 1 hour prior to surgery Group 7: 2 hours prior to surgery Group 8: 4 hours prior to surgery |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-03-01
- First posted
- 2008-10-02
- Last updated
- 2009-08-26
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00764582. Inclusion in this directory is not an endorsement.